share_log

Legend Biotech | 6-K: Legend Biotech Announced Results for the First Time from the Phase 2 CARTITUDE-2 Cohort D Study in Multiple Myeloma Patients

Legend Biotech | 6-K: Legend Biotech Announced Results for the First Time from the Phase 2 CARTITUDE-2 Cohort D Study in Multiple Myeloma Patients

傳奇生物 | 6-K:傳奇生物公佈西達基奧侖賽針對多發性骨髓瘤患者2期研究積極結果
美股sec公告 ·  06/03 16:09
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息